Site Map



About the Registry
The National Registry of Drug Induced Ocular Side-Effects was founded in 1976 in Little Rock, Arkansas by Dr. Frederick (Fritz) T. Fraunfelder. The goal was to create an international clearinghouse of drug information on adverse ocular events associated with drugs and biologics. The underlying principle of the Registry is to generate early signals of adverse ocular reactions secondary to medications based on suspicions of practicing clinicians.

In addition to collecting spontaneous reports from clinicians, the Registry accumulates data from the World Health Organization's Uppsala Monitoring Center, the Food and Drug Administration, pharmaceutical companies, and periodic screening of the world's literature.

The Registry maintains an extensive database specific only to ocular reactions caused by systemic or ocular medication. Dr. Fraunfelder's son Dr. Frederick (Rick) W. Fraunfelder, M.D. is the current director of the Registry with the mission remaining the same: to provide practicing clinicians with data on adverse ocular side effects which are not available anywhere else in the world.

All Case Reports, as well as any impressions, even without specific cases, are welcome and can be submitted here by registered users. Registration is free, but important for our records. To contact the Registry, call (503) 494-5686, or fax (503)494-4286. Case Reports may also be faxed, or mailed to:
National Registry of Drug-Induced Ocular Side Effects
3375 SW Terwilliger Blvd.
Portland, OR 97239-4197
Check Out What's New!
To get the latest on Current medications associated with ocular side effects, visit our What's New section.

Purchase the Book
This database supports the book Drug-Induced Ocular Side Effects, 5th ed., which is available for purchase at EHS Catalogs